Immunogenicity 9604

summary
Sample ID
3812
Response
Negative
Tumor Type
Bile duct cancer
Gene Symbol
IGLL1
Transcript ID
ENST00000330377
HLA INFO
DQA*01:03 / DQB*02:02
TCR INFO

No TCR info found!

T cell Tumor cell { DQA*01:03 DQB*02:02
sequence
Full length protein sequence (213 aa)
MRPGT
1
GQGGL
6
EAPGE
11
PGPNL
16
RQRWP
21
LLLLG
26
LAVVT
31
HGLLR
36
PTAAS
41
QSRAL
46
GPGAP
51
GGSSR
56
SSLRS
61
RWGRF
66
LLQRG
71
SWTGP
76
RCWPR
81
GFQSK
86
HNSVT
91
HVFGS
96
GTQLT
101
VLSQP
106
KATPS
111
VTLFP
116
PSSEE
121
LQANK
126
ATLVC
131
LMNDF
136
YPGIL
141
TVTWK
146
ADGTP
151
ITQGV
156
EMTTP
161
SKQSN
166
NKYAA
171
SSYLS
176
LTPEQ
181
WRSRR
186
SYSCQ
191
VMHEG
196
STVEK
201
TVAPA
206
ECS
211
Mutation Information
DNA mutation:
None
Peptide Range:
108 ~ 132
Mut AA position:
120 (13 in Wild Type peptide)
Alignment
Wild Type:
"SQPKATPSVTLFPPSSEELQANKAT
||||||||||||.||||||||||||
Mutant:
SQPKATPSVTLFTPSSEELQANKAT"
reference

Science, 2015

Immunogenicity of somatic mutations in human gastrointestinal cancers

Gene Name (from Reference) IGLL1

clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

None

Assay

IFNg ELISPOT assay